A Study of Chemotherapy With Durvalumab and Tremelimumab in NSCLC

February 9, 2017
Rosalyn Juergens, MD, PhD

Rosalyn Juergens, MD, PhD, assistant professor, Department of Oncology, Division of Medical Oncology, McMaster University, discusses a clinical trial investigating chemotherapy with durvalumab and tremelimumab in patients with non-small cell lung cancer (NSCLC).